News

Articularis Healthcare Group Broadens Reach with New Practice

Articularis Healthcare Group Broadens Reach with New Practice

Articularis Healthcare Group Expands National Reach

Articularis Healthcare Group (AHG), recognized as the nation's leading rheumatology management services organization, has made a significant move by opening a new practice in Knoxville. This opening marks a pivotal moment in AHG's mission to enhance community access to high-quality rheumatologic care.

Founded in 2015, AHG operates as a physician-led, independent healthcare management group that significantly assists private rheumatology practices. The organization provides a suite of operational services designed to empower rheumatologists to focus entirely on patient care. Their offerings comprise crucial components such as drug procurement, revenue optimization, financial services, and effective marketing strategies.

The recently inaugurated Articularis Rheumatology Specialists (ARS Knoxville) is under the expert leadership of Dr. Kenny Sizemore, a seasoned rheumatologist with three decades of experience. His background and dedication to serving patients have made him a respected figure in the Knoxville community.

Commitment to Community Care

Robert Kirk, the CEO of Articularis Healthcare Group, underscored the importance of community-based healthcare. "Community care is essential to our healthcare system, and AHG is committed to preserving and strengthening independent practices that put patients first," he stated. Dr. Sizemore and his team perfectly represent AHG's values of delivering compassionate and exceptional care, crucial to their mission.

As ARS Knoxville begins its operations, it aims to offer comprehensive, patient-centered rheumatologic care with services tailored to improve mobility, alleviate pain, and enhance patients' overall quality of life. The practice focuses on treating individuals managing chronic inflammatory, autoimmune, and musculoskeletal conditions.

Enhancing Patient Care and Quality of Life

The new practice also includes facilities for onsite specialty infusion therapies. Centrally located in Knoxville, ARS Knoxville is set to cater to patients from a broader region, ensuring effective treatment for various communities, including areas like Farragut and Maryville.

"We take immense pride in serving the Knoxville community with highly specialized rheumatology care," said Dr. Sizemore. His commitment to personalized care enables the team to create tailored treatment plans, assisting patients in leading fuller and healthier lives.

About Articularis Healthcare Group

Articularis Healthcare Group, Inc. (AHG) is the premier entity in the rheumatology management services sector, dedicated to fostering and enhancing community-based care. Established in 2015, AHG provides invaluable support to private practice rheumatologists through a combination of operational expertise, strategic partnerships, and technological innovations. This support allows practices to thrive while ensuring a consistent focus on delivering outstanding patient care.

AHG’s extensive management services encompass all aspects of practice operations, ensuring that each facility is equipped to provide superior care. The organization has established a vast network of practices across multiple states, currently operating 18 practices that are pivotal in their respective communities.

About Articularis Rheumatology Specialists

Articularis Rheumatology Specialists (ARS) specializes in providing comprehensive care to individuals dealing with autoimmune and inflammatory conditions. As a practice operating under the umbrella of AHG, ARS offers a unique approach that combines the latest medical treatments with compassionate patient care. With operational branches in several southern states, ARS is dedicated to fostering improved health outcomes and enhancing the quality of life for patients.

Frequently Asked Questions

What services does Articularis Rheumatology offer?

They provide patient-centered rheumatologic care, including specialized services for autoimmune and inflammatory conditions.

Who leads the new ARS Knoxville practice?

Dr. Kenny Sizemore, a board-certified rheumatologist with 30 years of experience.

When was Articularis Healthcare Group founded?

Articularis Healthcare Group was founded in 2015 and has expanded significantly since then.

Where is the new practice located?

The new ARS Knoxville practice is centrally located in Knoxville, serving patients throughout East Tennessee.

What is AHG's mission?

AHG's mission is to support independent practices and provide exceptional care that prioritizes community needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 34

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 38

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 51

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 39

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 21

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering States to Value Workforce Credentials Effectively

Updated Category News Views 207

Initiating FutureReady States for Workforce Empowerment The FutureReady States initiative, spearheaded by the Lumina Foundation, is a transformative approach to evaluating workforce credential effectiveness. This program is designed to help states understand and enhance their investment in workforce training policies that yield significant economic benefits for both...

Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns

Updated Category News Views 467

Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...

Continue Reading
Liberty HealthShare: A Compassionate Approach to Healthcare

Updated Category News Views 150

Liberty HealthShare: A Shift in Healthcare Sharing In recent years, many individuals have faced significant concerns about healthcare costs and insurance availability. Liberty HealthShare is stepping up to provide a compassionate alternative for those seeking an effective solution to diminishing healthcare options, especially amid rising premiums and decreasing coverage....

Continue Reading
SelectQuote, Inc. Announces Impressive Q2 Fiscal Results

Updated Category News Views 114

Record Quarter for SelectQuote, Inc. SelectQuote, Inc. (NYSE: SLQT) reported significant growth in its consolidated revenue for the second quarter of fiscal year 2025, reaching $481.1 million. This reflects a notable increase from $405.4 million in the same quarter of the prior year. Alongside revenue growth, the company achieved consolidated net income of $53.2 million,...

Continue Reading
Parker Hannifin to Reveal Fiscal 2025 Q2 Earnings Insights

Updated Category News Views 203

Parker Hannifin Corporation Upcoming Earnings Announcement Parker Hannifin Corporation (NYSE: PH), recognized as a global leader in motion and control technologies, has announced its plans to release its fiscal 2025 second quarter earnings. This exciting update is set to take place before the stock market opens on January 30, 2025. Investors and analysts eagerly...

Continue Reading